UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q/A

(Amendment No. 1)


FORM 10-Q


(Mark One)

Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarter Ended September 30, 2021.March 31, 2022

Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 (No fee required)

For the transition period from _______ to _______.

Commission file number: 000-27407

SPINE INJURY SOLUTIONS, INC.BITECH TECHNOLOGIES CORPORATION

(Name of Registrant in Its Charter)

Delaware

98-0187705

(State or Other Jurisdiction of
Incorporation or

Organization)

(I.R.S. Employer
Identification No.)

Organization)

5151 Mitchelldale
600 Anton Boulevard

Suite A21100

Houston, Texas   77092Costa Mesa, CA92626

(Address of Principal Executive Offices)

(713) 521-4220(855)777-0888

(Issuer’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.

Large accelerated filer ☐Accelerated filer ☐
Non-accelerated filerSmaller reporting company
Emerging growth company

Large accelerated filer ☐   Accelerated filer ☐   Non-accelerated filer ☒   Smaller reporting company ☒   Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

As of November 12, 2021,August 1, 2022, there were 20,240,882514,005,770 shares of the registrant’s common stock outstanding.

 

this Amendment No. 1 to the Form 10-Q for the period ended March 31, 2022 is to properly report the financial statements for that quarter and comparative quarter to reflect the previously disclosed share exchange pursuant to a Share Exchange Agreement (the “Share Exchange Agreement”) by and among Bitech Technologies Corporation (formerly, Spine Injury Solutions, Inc.) (the “Company”), Bitech Mining Corporation (“Bitech Mining”), each of Bitech Mining’s shareholders (each, a “Seller” and collectively, the “Sellers”), and Benjamin Tran, solely in his capacity as Sellers’ Representative (“Sellers’ Representative”). The transaction contemplated by the Share Exchange Agreement is hereinafter referred to as the “Share Exchange” and is disclosed in Note 4 to the Notes to Condensed Unaudited Financial Statements included in this report. Following completion of the Share Exchange, the Sellers owned a controlling interest in the Company.

 

The Share Exchange was treated as a recapitalization and reverse acquisition for financial reporting purposes, and Bitech Mining is considered the acquirer for accounting purposes. As a result of the Share Exchange and the change in our business and operations, a discussion of the past financial results of our predecessor, Spine Injury Solutions Inc., is not pertinent, and under applicable accounting principles, the historical financial results of Bitech Mining, the accounting acquirer, prior to the completion of the Share Exchange are considered the Company’s historical financial results.

The original filing of the Form 10-Q for the period ended March 31, 2022 erroneously reported the historical financial data of Spine Injury Solutions, Inc. rather than Bitech Mining Corporation, the acquirer for financial reporting purposes in accordance with Generally Accepted Accounting Principles.

FORM 10-Q10-Q/A

(Amendment No. 1)

TABLE OF CONTENTS

Note About Forward-Looking Statements

 
 

PART I

FINANCIAL INFORMATION

 
 

Item 1.

Condensed Consolidated Financial Statements

4
 

Condensed Consolidated Balance Sheets as of September 30, 2021March 31, 2022 (Unaudited) and December 31, 20202021

4

 

Condensed Consolidated Statements of Operations for the three and nine months ended September 30,March 31, 2022 and 2021 and 2020 (Unaudited)

5

 

Condensed Consolidated Statements of Cash Flows for the ninethree months ended September 30,March 31, 2022 and 2021 and 2020 (Unaudited)

6

 

Condensed Consolidated Statements of Changes in Shareholders’ Equity for the nine months ended September 30,as of March 31, 2022 and 2021 and 2020 (Unaudited)

7

 

Notes to Condensed Consolidated Financial Statements (Unaudited)

8

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

14

15
 

Item 3.

Quantitative and Qualitative Disclosure About Market Risk

16

20
 

Item 4.

Controls and Procedures

16

20
 

PART II

OTHER INFORMATION

 
 

Item 1A.

Risk Factors

17

21
 

Item 6.

2.

ExhibitsUnregistered Sales of Equity Securities and Use of Proceeds

18

21
 
Item 6.

SignaturesExhibits

22
 

19

Signatures24

2
Table of Contents


NOTE ABOUT FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q10-Q/A (Amendment No. 1) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, among other things, statements regarding plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements, which are other than statements of historical facts. Forward-looking statements may appear throughout this report, including without limitation, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements generally can be identified by words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “will be,” “will continue,” “will likely result,” and similar expressions. These forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties, which could cause our actual results to differ materially from those reflected in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this report and in our Annual Report on Form 10-K for the year ended December 31, 2020,2021, and in particular, the risks discussed in our Form 10-K under the caption “Risk Factors” in Item 1A therein,of this report and in in our Form 10-K, and those discussed in other documents we file with the Securities and Exchange Commission (“SEC”). Important factors that in our view could cause material adverse effects on our financial condition and results of operations include, but are not limited to, risks associated with entering into merger transaction with a private company, service demands and acceptance, our ability to expand, changes in healthcare practices, effects of the COVID 19 virus pandemic, changes in technology, economic conditions, the impact of competition and pricing, government regulation and approvals, impacts and disruptions caused by the COVID-19 pandemic and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. We undertake no obligation to revise or publicly release the results of any revision to any forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.

As used herein, the “Company,” “we,” “our,” and similar terms include Bitech Technologies Corporation (formerly Spine Injury Solutions, Inc.) and its subsidiaries and predecessors, unless the context indicates otherwise.

3
Table of Contents

 


PART II. FINANCIAL INFORMATION

ITEM1.FINANCIAL STATEMENTS

SPINE INJURY SOLUTIONS, INC.BITECH TECHNOLOGIES CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

  

SEPTEMBER 30,

  

DECEMBER 31,

 
  

2021

  

2020

 

ASSETS

 

(Unaudited)

     
         

Current assets:

        

Cash

 $17,598  $41,655 

Accounts receivable, net

  51,938   232,244 
         

Total current assets

  69,536   273,899 
         

Accounts receivable, net of allowance for doubtful accounts of $496,289 and

   $585,257 at September 30, 2021 and December 31, 2020, respectively

  -   - 

Property and equipment, net

  -   10,959 
         

Total assets

 $69,536  $284,858 
         

LIABILITIES AND STOCKHOLDERS DEFICIT

        
         

Current liabilities:

        

Note payable to shareholder

  430,000   490,000 

Accounts payable and accrued liabilities

  7,251   43,288 
         

Total current liabilities

  437,251   533,288 
         

Commitments and contingencies

        
         

Stockholders’ deficit:

        

Preferred stock: $0.001 par value, 10,000,000 shares authorized

        0 shares issued and outstanding

  -   - 

Common stock: $0.001 par value, 250,000,000 shares authorized, 20,240,882 shares issued and outstanding at both September 30, 2021 and December 31, 2020

  20,241   20,241 

Additional paid-in capital

  19,869,511   19,869,511 

Accumulated deficit

  (20,257,467

)

  (20,138,182)
         

Total stockholders’ deficit

  (367,715

)

  (248,430)
         

Total liabilities and stockholders’ deficit

 $69,536  $284,858 
  March 31,  December 31, 
  2022  2021 
   (Unaudited)     
ASSETS        
         
Current assets:        
Cash and cash equivalents $1,166,381  $976,947 
Accounts receivable, net of allowance for doubtful accounts of $0 and $0 at March 31, 2022 and December 31, 2021, respectively  2,272   - 
         
Total current assets  1,168,653   976,947 
         
Intangible Asset – Exclusive License  35,000   35,000 
         
Total assets $1,203,653  $1,011,947 
         
LIABILITIES AND STOCKHOLDERS’ EQUITY        
         
Current liabilities:        
Note payable to shareholder  395,000   - 
Accounts payable and accrued liabilities  96,854   11,106 
         
Total current liabilities  491,854   11,106 
         
Stockholders’ equity        
Preferred stock, $0.001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively  -   - 
Series A Convertible Preferred stock; $0.001 par value, 9,000,000 shares authorized, no shares issued and outstanding at March 31, 2022 and December 31, 2021  9,000   - 
Preferred stock, value  -   - 
Common stock: $0.001 par value, 250,000,000 shares authorized, 20,240,882 and 20,240,882 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively  20,241   20,241 
Additional paid-in capital  1,196,679   1,265,559 
Accumulated deficit  (514,121)  (284,959)
         
Total stockholders’ equity  711,799   1,000,841 
         
Total liabilities and stockholders’ equity $1,203,653  $1,011,947 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

4
Table of Contents

4

BITECH TECHNOLOGIES CORPORATION

SPINE INJURY SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

  

FOR THE THREE MONTHS ENDED

SEPTEMBER 30,

  

FOR THE NINE MONTHS ENDED

SEPTEMBER 30,

 
  

2021

  

2020

  

2021

  

2020

 
                 

Net service revenues

 $60,564  $21,566  $68,469  $87,015 

Lease revenues

  26,073   25,573   78,219   69,368 
                 

Total revenue

  86,637   47,139   146,688   156,383 
                 

Cost of providing services

  -   -   -   - 
                 

Gross profit

  86,637   47,139   146,688   156,383 
                 

Operating, general and administrative expenses

  89,679   121,908   280,453   385,642 
                 

Loss from operations

  (3,042

)

  (74,769

)

  (133,765

)

  (229,259

)

                 

Other income and (expense):

                

Other income

  35,000   -   35,050   453 

Interest expense

  (6,880

)

  (5,624

)

  (20,570

)

  (18,433

)

                 

Total other income and (expense)

  28,120   (5,624

)

  14,480   (17,980

)

                 

Net income (loss)

 $25,078  $(80,393

)

 $(119,285

)

 $(247,239

)

                 

Net loss per common share:

                

Basic/ diluted

 $0.00  $(0.00

)

 $(0.01

)

 $(0.01

)

                 

Weighted average shares outstanding:

                

Basic/ diluted

  20,240,882   20,240,882   20,240,882   20,240,882 
  For the Three
Months ended
March 31, 2022
  For the Three
Months ended
March 31, 2021
 
  (Unaudited)  (Unaudited) 
REVENUE        
Equipment Sales $-  $- 
Service Revenue  -   - 
Other Revenue  -   - 
TOTAL REVENUE  -   - 
         
COST OF REVENUE  -   - 
         
GROSS PROFIT  -   - 
         
OPERATING EXPENSES        
General & Administrative  229,162   17,131 
Total Operating Expenses  229,162   17,131 
         
LOSS FROM OPERATIONS  (229,162)  (17,131)
         
OTHER INCOME (EXPENSE)        
Miscellaneous Income (Expense)  -   - 
Interest Income  -   - 
Interest Expense  -   - 
         
Total Other Income (Expense)  -   - 
         
LOSS BEFORE INCOME TAXES  (229,162)  (17,131)
         
BENEFIT (PROVISION) FOR INCOME TAXES  -   - 
         
NET LOSS $(229,162) $(17,131)
         
BASIC AND DILUTED LOSS PER SHARE $(0.01) $(0.00)
         
WEIGHTED AVERAGE SHARES  20,240,882   20,240,882 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

5
Table of Contents

5

BITECH TECHNOLOGIES CORPORATION

SPINE INJURY SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

  

FOR THE NINE MONTHS ENDED

SEPTEMBER 30,

 
  

2021

  

2020

 

Cash flows from operating activities:

        

Net loss

 $(119,285

)

 $(247,239

)

Adjustments to reconcile net loss to net cash

provided by operating activities:

        

Provision for bad debts, net of recoveries

  -   12,323 

Depreciation expense

  10,959   10,815 

Changes in operating assets and liabilities:

        

Accounts receivable

  180,306   650,514 

Prepaid expenses and other assets

  -   12,314 

Accounts payable and accrued liabilities

  (36,037

)

  (32,096

)

         

Net cash provided by operating activities

  35,943   406,631 
         

Cash flows from financing activities:

        

 Proceeds of Paycheck Protection Program loan

  -   64,097 

Payments of note payable to a bank

  -   (460,000

)

 Payments of note payable to shareholder

  (60,000

)

  (65,000

)

         

Net cash used in financing activities

  (60,000

)

  (460,903

)

         

Net decrease in cash and cash equivalents

  (24,057

)

  (54,272

)

Cash and cash equivalents at beginning of period

  41,655   110,587 
         

Cash and cash equivalents at end of period

 $17,598  $56,315 
         

Supplementary disclosure of cash flow information:

        

Interest paid

 $20,569  $18,433 
         

Income taxes

 $-  $- 
         

Non-cash investing and financing activities:

        

Exchange of note payable to a bank for note payable to shareholder

 $-  $610,000 
  2022  2021 
  THREE MONTHS ENDED MARCH 31, 
  2022  2021 
Cash flows from operating activities:        
Net loss $(229,162) $(17,131)
Adjustments to reconcile net loss to net cash provided by operating activities:        
Depreciation expense  -   - 
Common Stock issued for services      9,700 
Common Stock issue for Exclusive License      10,000 
Changes in operating assets and liabilities:        
Accounts receivable, net  (2,271)  - 
Advances to Related Party  -   (3,119)
Prepaid expenses and other assets  -   - 
Accounts payable and accrued liabilities  85,747   - 
         
Net cash provided (used) by operating activities  (145,686)  (550)
         
Cash flows from investing activities:        
Purchase Intangible Asset – Exclusive License  -   (20,000)
         
Net cash used in investing activities  -   (20,000)
         
Cash flows from financing activities:        
Cash from Sale of Common Stock, net  -   100,100 
Notes Payable assumed in reverse merger  395,000     
Recapitalization – payments to SPIN  (59,880)    
         
Net cash provided by (used) in financing activities  335,120   100,100 
         
Net increase (decrease) in cash and cash equivalents  189,434   79,550 
Cash and cash equivalents at beginning of period  976,947   - 
         
Cash and cash equivalents at end of period $1,166,381  $79,550 
         
Supplementary disclosure of cash flow information:        
Interest paid $-  $- 
Taxes paid $-  $- 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

6
Table of Contents

6

SPINE INJURY SOLUTIONS, INC.

BITECH TECHNOLOGIES CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS (DEFICIT) EQUITY

(UNAUDITED)

For the nine months ended September 30, 2021 and 2020As of March 31, 2022

  

Common Stock

  

Additional

  

Accumulated

  

Total

Stockholders’

(Deficit)

 
  

Shares

  

Amount

  

Capital

  

Deficit

  

Equity

 

Balances, December 31, 2020

  20,240,882  $20,241  $19,869,511  $(20,138,182

)

 $(248,430

)

                     

Net loss

  -   -   -   (66,543

)

  (66,543

)

                     

Balances, March 31, 2021 (Unaudited)

  20,240,882   20,241   19,869,511   (20,204,725

)

  (314,973

)

                     

Net loss

  -   -   -   (77,820

)

  (77,820

)

                     

Balances, June 30, 2021 (Unaudited)

  20,240,882   20,241   19,869,511   (20,282,545

)

  (392,793

)

                     

Net income

  -   -   -   25,078   25,078 
                     

Balances, September 30, 2021 (Unaudited)

  20,240,882  $20,241  $19,869,511  $(20,257,467

)

 $(367,715

)

                     
                     

Balances, December 31, 2019

  20,240,882  $20,241  $19,869,511  $(19,840,788

)

 $48,964 
                     

Net loss

  -   -   -   (36,577

)

  (36,577

)

                     

Balances, March 31, 2020 (Unaudited)

  20,240,882   20,241   19,869,511   (19,877,365

)

  12,387 
                     

Net loss

  -   -   -   (130,269

)

  (130,269

)

                     

Balances, June 30, 2020 (Unaudited)

  20,240,882   20,241   19,869,511   (20,007,634

)

  (117,882)
                     

Net loss

  -   -   -   (80,393

)

  (80,393

)

                     

Balances, September 30, 2020 (Unaudited)

  20,240,882  $20,241  $19,869,511  $(20,088,027

)

 $(198,275)
  Shares  Amount  Shares  Amount  Capital  Deficit  (Deficit) 
  Common Stock  Preferred Stock  

Additional

Paid-In

  Accumulated  

Total

Stockholders’
Equity

 
  Shares  Amount  Shares  Amount  Capital  Deficit  (Deficit) 
                      
Balances, January 21, 2021 (inception)  20,240,882   20,241   -    -    1,265,559   -    1,285,800 
                             
Net loss  -   -      -    -   (284,959)  (284,959)
                             
Balances, December 31, 2021  20,240,882  $20,241   -    -   $1,265,559  $(284,959) $1,000,841 
Recapitalization                  (59,880)      (59,880)
                             
Series A Preferred Shares issued in Share Exchange          9,000,000   9,000   (9,000)      - 
                             
Net loss  -   -   -   -   -   (229,162)  (229,162)
Balances, March 31, 2022  20,240,882  $20,241   9,000,000  $9,000  $1,196,679  $(514,121) $711,799 

No dividends were paid for the ninethree months ended September 30, 2021March 31, 2022 and 2020.2021.

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

7
Table of Contents

7

BITECH TECHNOLOGIES CORPORATION

SPINE INJURY SOLUTIONS, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1.DESCRIPTION OF BUSINESS

Bitech Technologies Corporation (formerly, Spine Injury Solutions Inc.) (the “Company”, “we” or “us”) was incorporated under the laws of Delaware on March 4, 1998. In connection with the Company’s planned expansion of its business following the completion of the acquisition of Bitech Mining Corporation, a Wyoming corporation (“Bitech Mining”), it filed a Certificate of Amendment to its Certificate of Incorporation, as amended (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware on April 29, 2022 to change its corporate name to Bitech Technologies Corporation.

We changedare a development-stage technology company dedicated to providing a suite of green energy solutions which we call the Evirontek Integrated Platform with a focus on cryptocurrency mining, data centers, commercial and residential utility, electric vehicle, and other renewable energy initiatives. We seek to offer our nameEvirontek Integrated Platform to resolve the exorbitantly high cost of electricity in crypto mining and related industries. Our initial core technology is Tesdison; a revolutionary U.S. patented self-charging dual-battery system technology providing increased efficiency in power generation. We plan to seek business partnerships with renewable energy providers for various applications and engage with value-added resellers to facilitate and implement our scalable and modular system solution.

The Company acquired Bitech Mining on March 31, 2022 (the “Closing Date”) through a share exchange pursuant to a Share Exchange Agreement (the “Share Exchange Agreement”) by and among the Company, Bitech Mining, each of Bitech Mining’s shareholders (each, a “Seller” and collectively, the “Sellers”), and Benjamin Tran, solely in his capacity as Sellers’ Representative (“Sellers’ Representative”). The transaction contemplated by the Share Exchange Agreement is hereinafter referred to as the “Share Exchange”). The Share Exchange Agreement provides that the Company will acquire from Spine Pain Management Inc.the Sellers, an aggregate of 94,312,250 shares of Bitech Mining’s Common Stock, par value $0.001 per share, representing 100% of the issued and outstanding shares of Bitech Mining (collectively, the “Bitech Mining Shares”). In consideration of the Bitech Mining Shares, the Company issued to the Sellers an aggregate of 9,000,000 shares of the Company’s newly authorized Series A Convertible Preferred Stock, par value $0.001 per share (the “Series A Preferred Stock”). Each Bitech Mining Share shall be entitled to receive 0.09543 shares of Series A Preferred Stock. Each share of Series A Preferred Stock shall automatically convert into 53.975685 shares (an aggregate of approximately 485,781,300) of the Company’s Common Stock (the “Company Common Stock”) upon filing of an amendment to its Certificate of Incorporation increasing the number of the Company’s authorized common stock so that there are a sufficient number of shares of Company Common Stock authorized but unissued to permit a full conversion of all the Series A Preferred Stock. Upon conversion of the Series A Preferred Stock, the Sellers were expected to hold, in the aggregate, approximately 96% of the issued and outstanding shares of Company capital stock on a fully diluted basis.

The Share Exchange was treated as a recapitalization and reverse acquisition for financial reporting purposes, and Bitech Mining is considered the acquirer for accounting purposes. As a result of the Share Exchange and the change in our business and operations, a discussion of the past financial results of our predecessor, Spine Injury Solutions Inc. on October 1, 2015., is not pertinent, and under applicable accounting principles, the historical financial results of Bitech Mining, the accounting acquirer, prior to the Share Exchange are considered our historical financial results.

We are a technology, marketing, billing,Prior to March 31, 2022, we were engaged in the business of owning, developing and collection company facilitating diagnostic services for patients who have sustained spine injuries resulting from traumatic accidents.  We deliver turnkey solutionsleasing the Quad Video Halo video recording system (“QVH”) used to spine surgeons, orthopedic surgeons and other healthcare providers for necessary and appropriate treatment of musculo-skeletal spine injuries resulting from automobile and work-related accidents.  Our goal is to become a leader in providing technology and monetizing services to spine and orthopedic surgeons and other healthcare providers to facilitate proper treatment of their injured clients.  By monetizing the providers accounts receivable, which includes diagnostic testing and non-invasive surgical care, patients are not unnecessarily delayed or prevented from obtaining needed treatment.  By facilitating early treatment through affiliated doctors, we believe that health conditions can be prevented from escalating and injured victims can be quickly placed on the road to recovery.  Through our affiliate system, we facilitate spine surgeons, orthopedic surgeons and other healthcare providers to provide reasonable, necessary, and appropriate treatments to patients with musculo-skeletal spine injuries. We assist the centers that provide the spine diagnostic injections and treatment and pay the doctors a fee for therecord medical procedures they performed. After a patient is billed for the procedures performed by the affiliated doctor, we take control of the patient’s unpaid bill and oversee collection. In most instances, the patient is a plaintiff in an accident case, where the patient is represented by an attorney. Typically, the defendant (and/or the insurance company of the defendant) in the accident case pays the patient’s bill upon settlement or final judgment of the accident case. The payment to us is made through the attorney of the patient. In most cases, we must agree to the settlement price and the patient must sign off on the settlement. Once we are paid, the patient’s attorney can receive payment for his or her legal fee.

During the fourth quarter of 2018, the decision was made to discontinue our involvement in future medical procedures due to our cash position, and we were not involved in any procedures in 2021 and 2020 and will not do so unless we can access additional capital. However, we continue to actively pursueincluding the collection of accounts receivables related to previously funded procedures. Without additional funding, there is no guarantee that we can continue as a going concern.

We own a patented device and process by which a video recording system is attached to a fluoroscopic x-ray machine, the “four camera technology,” which we believe can attract additional physicians and patients as well as provide us with additional revenue streams with our new programs designed to assist in treatment documentation.  We have refined the technology, through research and development, resulting in a fully commercialized Quad Video Halo System 3.0.  Using this technology, diagnostic and treatment procedures are recorded from four separate video feeds that capture views from both inside and outside the body, and a video is made which is given to the patient’s representative to verify the treatment received.   

In September 2014, we created a wholly owned subsidiary, Quad Video Halo, Inc.  The purpose of this entity is to hold certain company assets affiliated with the QVH units.  

NOTE 2.GOING CONCERN CONSIDERATIONS

Since our inception in 1998, until commencement of ourprovided spine injury diagnostic operations in August, 2009, our expenses substantially exceeded our revenue, resulting in continuing losses and an accumulated deficit from operations of $15,004,698 as of December 31, 2009.  Since that time, our accumulated deficit has increased $5,252,769 to $20,257,467 as of September 30, 2021. Presently, we are trying to limit operating expenses toservices (collectively, the greatest extent possible. If in the future we decide to increase our service development, marketing efforts and/or brand building activities, we will need to increase our operating expenses and our general and administrative functions to support such growth in operations. No such growth in operations is presently planned. We are also actively seeking a private company with which to enter into a strategic business transaction, including a merger; however, we cannot predict the ultimate outcome of our efforts. Our continued existence is dependent upon our ability to successfully merge with a financially viable company, or our ability to increase revenue from services and obtain additional capital from borrowing and sales of our securities, as needed, to fund our operations. There is no assurance that a merger will be initiated or completed or that additional capital can be obtained or that it can be obtained on terms that are favorable to us and our existing stockholders. Any expectation of future profitability is dependent upon our ability to expand and develop our business, of which there can be no assurances. “QVH Business”).

8
8

Table of Contents

SPINE INJURY SOLUTIONS, INC.BITECH TECHNOLOGIES CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

During the fourth quarter of 2018, the decision was made to discontinue our involvement in future medical procedures due to our cash position, which hampered our ability to pay back existing debt to a current director and stockholder (see Note 5—Term Loan). We were not involved in any procedures in 2021 or 2020, and will not resume procedures unless we can access additional capital. The service revenue we previously earned has resulted in longer settlement times and a slowdown in cash collections. Additionally, our efforts to establish a market for the Quad Video Halo has not met our expectations, and we have cut back its development and operations. If we are unable to access additional capital in the near future, these recent developments could have a material negative impact on our financial performance and could have a material adverse effect on our results of operations and financial condition. As an alternative, we are also exploring possible strategic business transactions with third party companies.

We are actively pursuing a merger with a private company where they become the controlling company. We find this to be the best course of action for our stockholders. In July 2021, a private company signed a letter of intent to acquire us. In connection with the agreement, it paid $66,500 as a deposit to be applied to the total purchase price upon closing. Prior to the expiration date provided in the letter of intent, the agreement was terminated in September 2021. Upon termination of the agreement, $35,000 of the down payment was released to us and recognized as other income in the accompanying condensed consolidated statements of operations. The remaining $31,500 was held in trust at September 30, 2021 and was released to us in the fourth quarter of 2021.

Further, the COVID-19 pandemic has made it difficult for us to collect our accounts receivable, as attorney and medical offices are closed resulting in delayed settlements and medical procedures being canceled, which affects our lease revenue. We are uncertain how this pandemic will affect our ability to collect in the future or its overall effect on our lease revenue.

NOTE 3.2. CRITICAL ACCOUNTING POLICIES

The following are summarized accounting policies considered to be critical by our management:

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures, normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such SEC rules and regulations. Nevertheless, we believe that the disclosures are adequate to make the information presented not misleading. These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our 20202021 Annual Report as filed on Form 10-K. In the opinion of management, all adjustments, including normal recurring adjustments necessary to present fairly our financial position with respect to the interim condensed consolidated financial statements and the results of its operations for the interim period ended September 30, 2021,March 31, 2022, have been included. The results of operations for interim periods are not necessarily indicative of the results for a full year.

BasisRevenue recognition

The Company adopted Accounting Standards Codification (“ASC”) 606. ASC 606, Revenue from Contracts with Customers, establishes principles for reporting information about the nature, amount, timing and uncertainty of Consolidationrevenue and cash flows arising from the entity’s contracts to provide goods or services to customers. The core principle requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration that it expects to be entitled to receive in exchange for those goods or services recognized as performance obligations are satisfied.

The accompanying unaudited condensed consolidated financial statements includeCompany has assessed the accounts of Spine Injury Solutions, Inc. and its wholly owned subsidiary, Quad Video Halo, Inc. All material intercompany balances of transactions have been eliminated upon consolidation.

Accounting Method

Our financial statements are prepared using the accrual basis of accounting in accordance with U.S. GAAP.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist asimpact of the dateguidance by performing the following five steps analysis:

Step 1: Identify the contract

Step 2: Identify the performance obligations

Step 3: Determine the transaction price

Step 4: Allocate the transaction price

Step 5: Recognize revenue

Substantially all of the condensed consolidated financial statementsCompany’s revenue is derived from leasing equipment. The Company considers a signed lease agreement to be a contract with a customer. Contracts with customers are considered to be short-term when the time between signed agreements and satisfaction of the performance obligations is equal to or less than one year, and virtually all of the Company’s contracts are short-term. The Company recognizes revenue when services are provided to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services. The Company typically satisfies its performance obligations in contracts with customers upon delivery of the services. The Company does not have any contract assets since the Company has an unconditional right to consideration when the Company has satisfied its performance obligation and payment from customers is not contingent on a future event. Generally, payment is due from customers immediately at the invoice date, and the reported amountscontracts do not have significant financing components nor variable consideration. There are no returns and there is no allowances. All of revenuesthe Company’s contracts have a single performance obligation satisfied at a point in time and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherenttransaction price is stated in the preparation of our condensed consolidated financial statements; accordingly, it is possible that the actual results could differ from thesecontract, usually as a price per unit. All estimates and assumptions and could have a material effectare based on the reported amountsCompany’s historical experience, complete satisfaction of our financial positionthe performance obligation, and results of operations.the Company’s best judgment at the time the estimate is made.

9
9

Table of Contents

 

SPINE INJURY SOLUTIONS, INC.BITECH TECHNOLOGIES CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Revenue Recognition

The Company’s accounting for revenues is governed by two accounting standards. The Company’s service and product sale revenue are accounted for under ASC 606, Revenue from Contracts with Customers. Additionally, the Company’s QVH rental revenues are accounted for under ASC 842, Leases.

Service and Product Sale Revenue Recognition

Historically, our net revenues included service revenues that arose from the delivery of medical diagnostic services provided to the patient by medical professionals at the spine injury diagnostic centers, only after the patient completed and signed required medical and financial paperwork. Service revenues were recorded as net patient service revenues based on variable consideration elements further described below and in Note 4. While we do collect 100% of the accounts on certain patients, our historical collection rate was used to estimate the variable consideration expected and is reflected in the carrying balance of the accounts receivable and service revenue recorded.   A discount rate of 48%, based on payment history, was used to reduce revenue to 52% of Current Procedural Terminology code rates (“CPT” codes are numbers assigned to every task and service a medical practitioner may provide to a patient including medical, surgical and diagnostic services. CPT codes are developed, maintained and copyrighted by the American Medical Association). Patients were billed at the normal billing amount, based on national averages, for a particular CPT code procedure during the year ended December 31, 2018 and prior years. We recorded no revenue related to medical diagnostic services provided during the three or nine months ended September 30, 2021 and 2020, and revenue presented represents adjustments of variable consideration received for procedures performed in years prior to 2019.

Service revenue and corresponding accounts receivable are recognized by reference to “net revenue” and “accounts receivable, net” which is defined as gross amounts billed using CPT codes (“gross revenue”) less account discounts that are expected to result when individual cases are ultimately settled, which is the variable consideration associated with this revenue stream.

Lease Revenue

Rental revenues from operating leases are recognized on a straight-line basis over the term of the lease.  Rental billings for periods extending beyond period-end are recorded as deferred income and are recognized in the period earned.   For the QVH Leases, rental related services revenues for support, maintenance and video processing, delivery, and installation are lease related because the payments are considered minimum lease payments that are an integral part of the negotiated lease agreement with the customer.  These revenues are recognized on a straight-line basis over the term of the lease. As of September 30, 2021, the Company’s leases consisted solely of operating leases. As stated previously, we are uncertain on the effects of the COVID-19 pandemic on our lease revenue going forward.

Fair Value of Financial Instruments

Cash, accounts receivable, accounts payable, and accrued liabilities and notes payable as reflected in the condensed consolidated financial statements, approximates fair value. Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect thesethe estimates.

Cash and Cash Equivalents

Cash and cash equivalents consist of liquid investments with original maturities of three months or less. Cash equivalents are stated at cost, which approximates fair value. We maintain cash and cash equivalents in banks which at times may exceed federally insured limits. We have not experienced any losses on these deposits.

Property and Equipment

Property and equipment are carried at cost. When retired or otherwise disposed of, the related carrying cost and accumulated depreciation are removed from the respective accounts, and the net difference, less any amount realized from the disposition, is recorded in operations. Maintenance and repairs are charged to operating expenses as incurred. Costs of significant improvements and renewals are capitalized.

Property and equipment consist of computers and equipment and are depreciated over their estimated useful lives of three years, using the straight-line method.

Long-Lived Assets

We periodically review and evaluate long-lived assets when events and circumstances indicate that the carrying amount of these assets may not be recoverable. In performing our review for recoverability, we estimate the future cash flows expected to result from the use of such assets and its eventual disposition. If the sum of the expected undiscounted future operating cash flows is less than the carrying amount of the related assets, an impairment loss is recognized in the consolidated statements of operations. Measurement of the impairment loss is based on the excess of the carrying amount of such assets over the fair value calculated using discounted expected future cash flows.

Concentrations of Credit Risk

Assets that expose us to credit risk consist primarily of cash and accounts receivable. Our accounts receivable arearise from a diversified customer base and, therefore, we believe the concentration of credit risk is minimal. We evaluate the creditworthiness of customers before any services are provided. We record a discount based on the nature of our business, collection trends, and an assessment of our ability to fully realize amounts billed for services. In the third quarter, we reassessed variable consideration based on recent collection trends resulting in $50,000 of additional revenue. Additionally, weWe have established anno accounts receivable to warrant any allowance for doubtful accounts in the amount of $496,289 and $585,257, at September 30, 2021 andMarch 31, 2022 or December 31, 2020, respectively.2021.

10
10

Table of Contents

SPINE INJURY SOLUTIONS, INC.BITECH TECHNOLOGIES CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Stock Based Compensation

We account for the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors, including employee stock options, based on estimated fair values. Under authoritative guidance issued by the Financial Accounting Standards Board (“FASB”), companies are required to estimate the fair value or calculated value of share-based payment awards on the date of grant using an option-pricing model. The value of awards that are ultimately expected to vest is recognized as expense over the requisite service periods in our consolidated statements of operations. We use the Black-Scholes Option Pricing Model to determine the fair-value of stock-based awards. During the three months ended March 31, 2022 and 2021, we did not recognize any compensation expense during those periods.

Income Taxes

We account for income taxes in accordance with the liability method. Under the liability method, deferred assets and liabilities are recognized based upon anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax basis. We establish a valuation allowance to the extent that it is more likely than not that deferred tax assets will not be utilized against future taxable income.

Uncertain Tax Positions

Accounting Standards Codification “ASC” Topic 740-10-25 defines the minimum threshold a tax position is required to meet before being recognized in the financial statements as “more likely than not” (i.e., a likelihood of occurrence greater than fifty percent). Under ASC Topic 740-10-25, the recognition threshold is met when an entity concludes that a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination by the relevant taxing authority. Those tax positions failing to qualify for initial recognition are recognized in the first interim period in which they meet the more likely than not standard or are resolved through negotiation or litigation with the taxing authority, or upon expiration of the statute of limitations. De-recognition of a tax position that was previously recognized occurs when an entity subsequently determines that a tax position no longer meets the more likely than not threshold of being sustained.

We are subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, we may incur additional tax expense based upon the outcomes of such matters. In addition, whenWhen applicable, we will adjust tax expense to reflect our ongoing assessments of such matters which require judgment and can materially increase or decrease our effective rate as well as impact operating results.

Under ASC Topic 740-10-25, only the portion of the liability that is expected to be paid within one year is classified as a current liability. As a result, liabilities expected to be resolved without the payment of cash (e.g. resolution due to the expiration of the statute of limitations) or are not expected to be paid within one year are not classified as current. Estimated interest and penalties if any, are recognized as income tax expense and tax credits as a reduction in income tax expense. For the three and nine monthsyear ended September 30,December 31, 2021, and 2020, we recognized no estimated interest or penalties as income tax expense.

Legal Costs and Contingencies

In the normal course of business, we incur costs to hire and retain external legal counsel to advise us on regulatory, litigation and other matters. We expense these costs as the related services are received.

If a loss is considered probable and the amount can be reasonably estimated, we recognize an expense for the estimated loss. If we have the potential to recover a portion of the estimated loss from a third party, we make a separate assessment of recoverability and reduce the estimated loss if recovery is also deemed probable.

11
Table of Contents

BITECH TECHNOLOGIES CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Net Income (Loss)Loss per Share

Net income (loss)Basic and diluted net loss per common share is presented in accordance with ASC Topic 260, “Earnings per Share,” for all periods presented. During the three and nine months ended September 30,March 31, 2022 and 2021, and 2020, common stock equivalents from outstanding stock options warrants and convertible debtwarrants have been excluded from the calculation of the diluted earnings (loss)loss per share in the consolidated statements of operations, because all such securities were anti-dilutive. The income (loss)net loss per share is calculated by dividing the net income (loss)loss by the weighted average number of shares outstanding during the periods.

11

SPINE INJURY SOLUTIONS, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Recent Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU No. 2016-13 eliminates the probable initial recognition threshold in current U.S. GAAPgenerally accepted accounting principles (“GAAP”) and, instead, requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. In addition, ASU No. 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. In November 2019, the FASB issued ASU No. 2019-10 to amend the effective date for entities that had not yet adopted ASU No. 2016-13. Accordingly, the provisions of ASU No. 2016-13 was initiallyare effective for annual periods beginning after December 15, 2020,2022, with early application permitted in annual periods beginning after December 15, 2018. In November 2019, the FASB issued ASU 2019-10 which amended the effective date for small reporting companies to fiscal years beginning after December 15, 2022. The amendments of ASU No. 2016-13 should be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Management is currently evaluating the future impact of ASU No. 2016-13 on the Company’s consolidated financial position, results of operations and disclosures.

NOTE 4.3. STOCKHOLDERS’ EQUITYACCOUNTS RECEIVABLE

The patients are billed by the healthcare provider based on Current Procedural Terminology (“CPT”) codes for the medical procedure performed. CPT codes are numbers assigned to every task and service a medical practitioner may provide to a patient including medical, surgical and diagnostic services. CPT codes are developed, maintained and copyrighted by the American Medical Association. Patients are billed at the normal billing amount, based on national averages, for a particular CPT code procedure.

Revenue and corresponding accounts receivable are recognized by reference to “net revenue” and “accounts receivable, net” which is defined as gross amounts billed using CPT codes less account discounts that are expected to result when individual cases are ultimately settled.  While we do collect 100% of the accounts on some patients, our historical collection rate is used to calculate the carrying balance of the accounts receivable and the estimated revenue to be recorded.  

The patients who receive medical services at the diagnostic centers are typically patients involved in auto accidents or work injuries. The patient completes and signs medical and financial paperwork, which includes an acknowledgement of the patient’s responsibility of payment for the services provided. Additionally, the paperwork should include an assignment of benefits.  The timing of collection of receivables varies depending on patient sources of payment. Historical experience, through 2018, demonstrated that the collection period for individual cases may extend for two years or more.

Our credit policy has been established based upon extensive experience by management in the industry and has been determined to ensure that collectability is reasonably assured.  Payment for services are primarily made to us by a third party and the credit policy includes terms of net 240 days for collections; however, collections occur upon settlement or judgment of cases. As of September 30, 2021 and December 31, 2020, we determined an allowance for uncollectable accounts of $496,289 and $585,257, respectively, was needed for those customer accounts whose collections appear doubtful.

NOTE 5.  TERM LOAN

On August 31, 2020, Peter L. Dalrymple, a member of our board of directors, paid-off in full the outstanding balance of a term loan we had with Wells Fargo Bank, N.A. As consideration for Mr. Dalrymple paying off the term loan on our behalf, we issued Mr. Dalrymple a $610,000 one-year secured promissory note. The secured promissory note bears interest of 6% per year with monthly payments of interest only due until maturity, when all unpaid interest and principal is due. This note is collateralized by all of our accounts receivable and a pledge of the stock of our wholly owned subsidiary, Quad Video Halo, Inc. The secured promissory note balance was $430,000 and $490,000 at September 30, 2021 and December 31, 2020, respectively. In October 2021, the Company and Mr. Dalrymple amended the promissory note to extend the maturity date to June 30, 2022.

On October 28, 2021, the Company and Mr. Dalrymple entered into a letter agreement whereby the Company transferred certain accounts receivable having a gross balance of $84,865 to an entity owned by Mr. Dalrymple as consideration for a $33,946 reduction in the balance of the promissory note.

During the three and nine months ended September 30, 2021, the Company recorded interest expense of $6,880 and $20,569, respectively, on the Peter Dalrymple note. During the three and nine months ended September 30, 2020, the Company recorded $2,281 and $15,090, respectively, on the Wells Fargo term loan and $3,343 on the Peter Dalrymple note for the period from note inception, August 31, 2020, through September 30, 2020.

12

SPINE INJURY SOLUTIONS, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 6.  STOCKHOLDERS EQUITY

The total number of authorized shares of our common stock is was 250,000,000 shares $0.001 par value per share. As of September 30, 2021, there were 20,240,882 common shares issued and outstanding. We did not issue any shares of common stock for the three and nine months ended September 30, 2021.at March 31, 2022.

On January 19, 2021, our stockholders approved the filing of an amendment to our certificate of incorporation authorizing 10,000,000 shares of preferred stock with a par value of $0.001$0.001 per share. Such amendment was filed on January 20, 2021. We did not issue any

12
Table of Contents

BITECH TECHNOLOGIES CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

On March 30, 2022, the Secretary of State of Delaware acknowledged the Company’s filing of a Certificate of Designations of Preferences and Rights of Series A Convertible Preferred Stock (the “Certificate of Designations”) with the Delaware Secretary of State creating a series of 9,000,000 shares of preferredSeries A Preferred Stock (the “Series A Preferred Stock”) to be issued in connection with the Share Exchange. The Certificate of Designations include:

the stated value of each share is $1.00 (the “Stated Value”),
each share has 53.9757 votes per share on any matter, event or action submitted to the holders of our common stock for a vote or on which the holders of our common stock have a right to vote,
each share is automatically convertible into shares of our common stock determined by dividing (i) the Stated Value by (ii) the Conversion Price then in effect. Initially, the “Conversion Price” is $0.018526887 per share, subject to adjustment as described below on the first business day immediately following the earlier of (a) the date on which the Secretary of State of Delaware shall have filed the Certificate of Designations; and (b) the date on which FINRA has affected a reverse stock split of the Company’s outstanding common stock, after all required approvals by the Company’s board of directors and its stockholders, in either (a) or (b), so that there are a sufficient number of shares of the Company’s Common Stock authorized but unissued to permit a full conversion of all the Series A Preferred Stock based upon the Conversion Price,
the conversion price of the Series A Preferred Stock is subject to proportional adjustment in the event of stock splits, stock dividends and similar corporate events, and
upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary (a “Liquidation”), each holder of the Series A Preferred Stock shall be entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, plus any other fees or liquidated damages then due and owing thereon under the Certificate of Designations, for each share of Series A Preferred Stock before any distribution or payment shall be made to the holders of any junior securities (as hereinafter defined), and if the assets of the Company shall be insufficient to pay in full such amounts, then the entire assets to be distributed to each holder of the Series A Preferred Stock shall be ratably distributed among each such holder in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full.

On March 31, 2022, we issued 9,000,000 shares of Series A Preferred Stock in exchange for 94,312,250 shares of Bitech Mining’s Common Stock, par value $0.001 per share, representing 100% of the threeissued and nine months ended September 30, 2021.outstanding shares of Bitech Mining.

NOTE 4. ACQUISITION OF BITECH MINING

On March 31, 2022, the Company acquired 94,312,250 shares of Bitech Mining’s Common Stock in exchange for 9,000,000 shares of its Series A Preferred Stock representing 100% of the issued and outstanding shares of Bitech Mining.

The Share Exchange was treated as a recapitalization and reverse acquisition for financial reporting purposes, and Bitech Mining is considered the acquirer for accounting purposes. As a result of the Share Exchange and the change in our business and operations, a discussion of the past financial results of our predecessor, Spine Injury Solutions Inc., is not pertinent, and under applicable accounting principles, the historical financial results of Bitech Mining, the accounting acquirer, prior to the Share Exchange are considered our historical financial results.

The Combination of the Company and Bitech Mining is considered a business acquisition and the method used to present the transaction is the acquisition method. The acquisition method is a method of accounting for a merger of two businesses. The tangible assets and liabilities and operations of the acquired business were combined at their market value of the acquisition date, which is the date when the acquirer gains control over the acquired company

The following table summarizes the consideration paid for Bitech Mining and the fair value amounts of assets acquired and liabilities assumed recognized at the acquisition date:

SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES

     
Purchase price $1,113,679 
     
Cash $1,150,163 
Total assets: $1,185,163 
Less: liabilities assumed $(71,484)
Net assets acquired $1,113,679 
Purchase price in excess of net assets acquired $0 

13
Table of Contents

BITECH TECHNOLOGIES CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 7.  INCOME TAXES5. RELATED PARTY TRANSACTIONS

Up until March 31, 2022, the Company maintained its executive offices at 5151 Mitchelldale A2, Houston, Texas 77092. This office space encompasses approximately 200square feet and was provided to us at the rental rate of $1,000 per month under a month-to-month agreement with Northshore Orthopedics, Assoc. (“NSO”), a company owned by William Donovan, M.D., our former director and Chief Executive Officer. The rent included the use of the telephone system, computer server, and copy machines. We discontinued paying rent in December 2021 due to a lack of funds, and since then NSO has provided the Company this office space rent free.

NOTE 6. SUBSEQUENT EVENTS

On April 14, 2022, the Company issued 3,348,000 shares of its restricted Common Stock to an individual as compensation for future services at a fair value price on the date of issuance of $0.10 per share. 1,802,769 shares vest on April 13, 2023 and 515,077 shares vest on April 13, 2024, April 13, 2025, and April 13, 2026 so long as the individual is providing services to the Company or one of its subsidiaries.

On April 19, 2022, the Company issued 4,635,720 shares of its restricted Common Stock to an individual as compensation for future services at a fair value price on the date of issuance of $0.10 per share. The shares vest 25% on each April 18 commencing on April 18, 2023 so long as the individual is providing services to the Company or one of its subsidiaries.

Effective as of July 8, 2022, the Financial Industry Regulatory Authority, Inc. (“FINRA”) confirmed that it had received the necessary documentation to process the Company’s request to change its name and trading symbol previously disclosed in its Form 8-K filed with the Securities and Exchange Commission on May 2, 2022. The Company’s ticker symbol on the OTCQB tier of the OTC Markets Group. Inc. was changed to “BTTC” on July 8, 2022.

 

14
Table of Contents

We have not made a provision for income taxes for the three and nine months ended September 30, 2021 or 2020, which reflects our valuation allowance established against our benefits from net operating loss carryforwards.

NOTE 8.  LEASE REVENUES

The Company’s QVH unit rentals are governed by agreements that detail the lease terms and conditions. The determination of whether these contracts with customers contain a lease generally does not require significant judgement. The Company accounts for these rentals as operating leases. These leases do not include material amounts of variable payments and the Company has made the accounting policy election to exclude all taxes assessed by a governmental authority. The Company provides an option of the lessee to purchase the rented equipment upon the termination of the lease for the as then fair market value; however, the Company has not generated material revenue from sales of equipment under such options. Initial lease terms vary in length based upon customer needs and generally range from 12 to 36 months. Customers have the option to keep equipment on rent beyond the initial lease term on a one-year successive term that auto renews unless canceled by the customer. All of the Company’s rental products have long useful lives relative to the typical rental term with the original investment typically recovered in approximately five years. The rental products are typically rented for a majority of the time owned and a significant portion of the original investment is recovered when sold from inventory. The Company’s lease agreements do not contain residual value guarantees or restrictive covenants.

All of the Company’s outstanding lease contracts as of September 30, 2021, are scheduled to mature during the remainder of 2021 with expected operating lease payments to be received totaling approximately $25,000.

The carrying value of equipment available for rent totaled $0 and $10,959 as of September 30, 2021 and December 31, 2020, respectively, and is included in property and equipment, net in the accompanying condensed consolidated balance sheets.

13

ITEM 2.MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following

This management discussion and analysis (“MD&A”) of the financial condition and results of operations of Bitech Technologies Corporation (the “Company,” “Bitech Technologies,” “our” or “we”) is for the three months ended March 31, 2022 and 2021 and for period January 21, 2022 (inception) through December 31, 2021. It is supplemental to, and should be read in conjunction with, our unaudited condensed consolidated financial statements for the three months ended March 31, 2022 and the related notes to the2021 and our financial statements included in this Form 10-Q.

Critical Accounting Policies

See Note 3 offor the period January 21, 2021 (inception) through December 31, 2021 and the accompanying notes to unaudited condensed consolidatedfor such period included in our Current Report on Form 8-K filed with the Securities and Exchange Commission, or SEC, on April 4, 2022. Our financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Financial information presented in this MD&A is presented in United States dollars (“$” or “US$”), unless otherwise indicated.

The information about us provided in this MD&A, including information incorporated by reference, may contain “forward-looking statements” and certain “forward-looking information” as defined under applicable United States securities laws and Canadian securities laws. All statements, other than statements of historical fact, made by us that address activities, events or developments that we expect or anticipate will or may occur in the future are forward-looking statements, including, but not limited to, statements preceded by, followed by or that include words such as “may”, “will”, “would”, “could”, “should”, “believes”, “estimates”, “projects”, “potential”, “expects”, “plans”, “intends”, “anticipates”, “targeted”, “continues”, “forecasts”, “designed”, “goal”, or the negative of those words or other similar or comparable words and includes, among others, information regarding: our ability to become profitable and generate cash in our operating activities; our need for substantial additional financing to operate our business and difficulties we may face acquiring additional financing on terms acceptable to us or at all; our significant indebtedness and significant restrictions on our operations; our ability to develop and manufacture each of the components of our planned Evirontek Integrated Platform; the impact of global climate change on our ability to conduct future operations; our dependence on key inputs, suppliers and skilled labor for the production of each of the components of the Evirontek Integrated Platform; our ability to attract and retain key personnel; growth-related risks, including capacity constraints and pressure on our internal systems and controls; risk related to the protection of our intellectual property and our exposure to infringement or misappropriation claims by third parties; risks related to competition; risks related to our lack of internal controls over financial reporting and their effectiveness; increased costs we are subject to as a result of being a public company in the United States; and other events or conditions that may occur in the future.

Forward-looking statements may relate to future financial conditions, results of operations, plans, objectives, performance or business developments. These statements speak only as at the date they are made and are based on information currently available and on the then current expectations of the party making the statement and assumptions concerning future events, which noteare subject to a number of known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from that which was expressed or implied by such forward-looking statements, including, but not limited to, risks and uncertainties described in “Risk Factors.”

Although we believe that the expectations and assumptions on which such forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements, because no assurance can be given that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to the risks described in “Risk Factors.”

15
Table of Contents

Consequently, all forward-looking statements made in this MD&A and other documents, as applicable, are qualified by such cautionary statements, and there can be no assurance that the anticipated results or developments will actually be realized or, even if realized, that they will have the expected consequences to or effects on us. The cautionary statements contained or referred to in this section should be considered in connection with any subsequent written or oral forward-looking statements that we and/or persons acting on its behalf may issue. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required under securities legislation.

Overview of the Business

We are a development-stage technology company dedicated to providing a suite of green energy solutions which we call the Evirontek Integrated Platform with a focus on cryptocurrency mining, data centers, commercial and residential utility, electric vehicle, and other renewable energy initiatives. We seek to offer our Evirontek Integrated Platform to resolve the exorbitantly high cost of electricity in crypto mining and related industries. Our initial core technology is incorporated hereinTesdison; a revolutionary U.S. patented self-charging dual-battery system technology providing increased efficiency in power generation. We plan to seek business partnerships with renewable energy providers for various applications and engage with value-added resellers to facilitate and implement our scalable and modular system solution.

There is an urgency in the global needs of today’s ever-changing energy landscape in the world of cryptocurrency mining where power saving is the most challenging issue for this business. Our goal is to change the future of the cryptocurrency mining businesses by reference.providing our patented revolutionary green technology power-saving solution that has been designed to be safe, reliable, cost effective, and easily scalable.

We plan to initially market the Evirontek Integrated Platform to the cryptocurrency mining industry to reduce the exorbitant high cost of electricity. The Evirontek Integrated Platform, once fully developed, will be comprised of (1) a patented high efficiency electric power generation and charging system which we license and call the “Tesdison Technology”, (2) a chipset and related software component we plan to develop which we call the “Bitech Intellisys-8 Chipset Solution” or “Intellisys-8”, (3) Battery Energy Storage Systems (BESS) technology solution for power grid efficiency, and (4) other complementary clean energy technologies that we plan to acquire. Combined, we refer to these technologies as the Evirontek Integrated Platform.

To respond to the current increasing demand in energy efficiency solutions while expanding our potential revenue options, we also plan to (1) become a Resource Entity (RE) operating our own state-of-the-art Battery Energy Storage Systems (BESS) solution in order to re-optimize the power capacity and balance the grid with intelligent time peak shifting control, and (2) penetrate into the solar power plant market and partner with or acquire outdated, mid-field solar power plants in the U.S., especially in California and Texas, and implement a BESS solution to increase energy efficiency and monetize time peak shifting implementation with targeted power plants ranging from 20MW to 500MW. Our planned containerized BESS solution is expected to provide a high level of user-friendly and seamless integration, intelligent monitoring ability with multimode authorization for dynamic connection, ultimate safety features, and flexible application via modular design, while enhancing robustness for interference from external factors in the field.

16
Table of Contents

The Company acquired Bitech Mining Corporation, a Wyoming corporation (“Bitech Mining”) on March 31, 2022 (the “Closing Date”) through a share exchange pursuant to a Share Exchange Agreement (the “Share Exchange Agreement”) by and among the Company, Bitech Mining, each of Bitech Mining’s shareholders (each, a “Seller” and collectively, the “Sellers”), and Benjamin Tran, solely in his capacity as Sellers’ Representative (“Sellers’ Representative”). The transaction contemplated by the Share Exchange Agreement is hereinafter referred to as the “Share Exchange”). The Share Exchange Agreement provides that the Company will acquire from the Sellers, an aggregate of 94,312,250 shares of Bitech Mining’s Common Stock, par value $0.001 per share, representing 100% of the issued and outstanding shares of Bitech Mining (collectively, the “Bitech Mining Shares”). In consideration of the Bitech Mining Shares, the Company issued to the Sellers an aggregate of 9,000,000 shares of the Company’s newly authorized Series A Convertible Preferred Stock, par value $0.001 per share (the “Series A Preferred Stock”). Each Bitech Mining Share shall be entitled to receive 0.09543 shares of Series A Preferred Stock. Each share of Series A Preferred Stock shall automatically convert into 53.975685 shares (an aggregate of approximately 485,781,300) of the Company’s Common Stock (the “Company Common Stock”) upon filing of an amendment to its Certificate of Incorporation increasing the number of the Company’s authorized common stock so that there are a sufficient number of shares of Company Common Stock authorized but unissued to permit a full conversion of all the Series A Preferred Stock. Upon conversion of the Series A Preferred Stock, the Sellers will hold, in the aggregate, approximately 96% of the issued and outstanding shares of Company capital stock on a fully diluted basis.

 

Management OverviewThe Share Exchange was treated as a recapitalization and reverse acquisition for financial reporting purposes, and Bitech Mining is considered the acquirer for accounting purposes. As a result of the Share Exchange and the change in our business and operations, a discussion of the past financial results of our predecessor, Spine Injury Solutions Inc., is not pertinent, and under applicable accounting principles, the historical financial results of Bitech Mining, the accounting acquirer, prior to the Share Exchange are considered our historical financial results.

 

In July 2021, a private company signed a letter of intent to acquire us. InThe following agreements were entered into in connection with the agreement, it paid $66,500acquisition of Bitech Mining:

Management Services Agreement

On the Closing Date, the Company, Quad and Peter L. Dalrymple (“Dalrymple”), a former director of the Company, entered into a Management Services Agreement (the “MSA”) whereby Dalrymple agreed to act as the general manager of the video recording operations of Quad and collect certain accounts receivable of the Company (the “Services”). In exchange for providing the Services, the Company agreed to pay Dalrymple a deposit to be appliedfee equal to the total purchase pricenet revenues derived from these operations after payment of all operating expenses related to such operations. The term of the MSA commences on the Closing Date and continues until the earlier to occur of the following: (i) 90 days after the Closing Date; (ii) the Company and Dalrymple’s mutual written consent; or (iii) any material breach of the MSA by either party, provided that the breaching party has been provided written notice of such breach and has failed to cure such breach within ten (10) days of receipt of such written notice.

Amendment to the Note

On the Closing Date, the Company, Quad and Dalrymple, entered into an Amendment to the Secured Promissory Note (the “Note Amendment”) whereby Dalrymple agreed that (i) the principal and accrued interest outstanding under the Secured Promissory Note dated August 31, 2020 as amended on October 29, 2021 issued by the Company in favor of Dalrymple (collectively, the “Note”) is $95,000 as of the Closing Date, (ii) the date on which the outstanding principal and accrued interest is due is 90 days after the Closing Date, (iii) any obligations of (x) the Company that become due and owing to Bitech Mining or the Sellers under Section 4.07(c) of the Share Exchange Agreement or (y) that become due and owing under Section 6.12 of the MSA may be offset against any amounts owed by the Company or Quad under the Note and (iv) all claims or causes of action (whether in contract or in tort, in law or in equity) that may be based upon, closing. arise out of or relate to the Note, or the negotiation, execution or performance of the Note (including any representation or warranty made in or in connection with the Note or as an inducement to enter into the Note or this Amendment), may be made only against Quad, and SPIN who is not a party to the Note as of the Closing Date, including without limitation any past, present or future director, officer, employee, incorporator, member, manager, partner, equity holder, affiliate, agent, attorney or representative of SPIN (“SPIN Parties”), shall have no liability (whether in contract or in tort, in law or in equity, or based upon any theory that seeks to impose liability of the SPIN Parties) for any obligations or liabilities arising under, in connection with or related to the Note or for any claim based on, in respect of, or by reason of the Note or its negotiation or execution, and Dalrymple waives and releases all such liabilities, claims and obligations against any such SPIN Parties.

17
Table of Contents

Amendment to the Security Agreement

On the Closing Date, the Company, Quad and Dalrymple, entered into an Amendment to Security Agreement (the “Security Agreement Amendment”) whereby the parties to that agreement agreed that (i) Quad shall be included with the Company as an additional debtor for all purposes in the Security Agreement entered into between the Company and Dalrymple dated August 31, 2020 (the “Security Agreement”), (ii) Quad’s collateral obligations under the Security Agreement shall only relate to its accounts receivable, and the collateral described relating to “Pledged Securities” as defined in the Security Agreement shall not apply to Quad’s obligations under the Security Agreement, (iii) the Company’s pledge of its accounts receivables as provided for in the Security Agreement will be limited solely to the Company’s accounts receivables in existence as of March 27, 2022 at 11:59 P.M. ET, and shall not apply to any after acquired accounts receivables and (iv) the Company is authorized to file an amended financing statement to reflect the terms of Security Agreement Amendment and Quad shall promptly file a financing statement reflecting the terms set for in such amendment.

Prior to the expiration date providedMarch 31, 2022, we were engaged in the letterbusiness of intent, the agreement was terminated in September 2021. Upon termination of the agreement, $35,000 of the deposit was released to usowning, developing and recognized as other income in the accompanying condensed consolidated statements of operations. The remaining $31,500 was held in trust at September 30, 2021 and was released to us in the fourth quarter of 2021.

During the fourth quarter of 2018, the decision was made to discontinue involvement in future medical procedures due to our cash position, which also hampers our ability to pay back existing debt to a current director and stockholder. We did not perform any procedures in 2021 thus far or in 2020 and will not resume procedures unless we can access additional capital. The service revenue we previously earned has resulted in longer settlement times and a slowdown in cash collections. Additionally, despite our efforts to establish a market forleasing the Quad Video Halo such market has not met our expectations and we have cut back its development and operations.

Moving forward, our main focus will be collectingvideo recording system (“QVH”) used to record medical procedures including the collection of accounts receivable, paying down debt and leveraging our position as a fully reporting public company for other investing opportunities.

There can be no guarantee of us continuing as a going concern if we cannot obtain additional funds.

We are actively pursuing a merger with a private company where they becomereceivables related to previously provided spine injury diagnostic services (collectively, the controlling company. We find this to be the best course of action for our stockholders.“QVH Business”).

Additionally, the COVID-19 pandemic has made it difficult for us to collect our accounts receivable, as attorney and medical offices are closed resulting in delayed settlements and medical procedures being canceled, which affects our lease revenue. We are uncertain how this pandemic will affect our ability to collect in the future or its overall effect on our lease revenue.

Results of Operations

The unaudited financial statements for the nine months ended September 30, 2021 and 2020 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with instructions to Form 10-Q. In the opinion of management, the unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position as of September 30, 2021 and the results of operations and cash flows for the three and nine months ended September 30, 2021 and 2020. The results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the entire year ending December 31, 2021 or any subsequent period.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the Securities and Exchange Commission’s rules and regulations. These unaudited financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended December 31, 2020 as included in our previously filed report on Form 10-K.

14

Comparison of the three-monththree month period ended September 30, 2021March 31, 2022 with the three month-periodmonth period ended September 30, 2020.March 31, 2021.

The revenueCompany has not generated any revenues from its primary business for the three months ended September 30, 2021 of $86,637 consisted of $26,073 of QVH leasing revenue,March 31, 2022 and $60,564 of service revenues consisting of excess collections on previously performed procedures totaling $10,564 and a revision to our estimated variable consideration totaling $50,000. The revenue for the three months ended September 30, 2020 of $47,139 consisted of $25,573 of QVH leasing revenue, and $21,566 related to excess collections for previously performed procedures. March 31, 2021.

During the three months ended September 30, 2021,March 31, 2022, we incurred $89,679$229,162 of operating, general and administrative expenses compared to $121,908$17,131 for the same period in 2020. Operating, general2021. General and administrative expenses were lower for the 2021 quarterhave increased during 2022 compared to 2020 primarily because of decreases in payroll expenses of $13,103, legal fees of $5,285, consulting fees of $17,112, and $6,007 of insurance expense and other miscellaneous expense of approximately $4,000.

Other income for2021 as the three months ended September 30, 2021 totaled $28,120 comparedCompany moves from development stage to other expense of $5,624 during the comparable prior year period. The change reflects the $35,000 received as a deposit from a private company seeking to acquire us, which was recognized as other income upon termination of the agreement.revenue generation.

As a result of the foregoing, we had net incomeloss of $25,078($229,162) for the three months ended September 30, 2021,March 31, 2022, compared to a net loss of $80,393($17,131) for the three months ended September 30, 2020.March 31, 2021.

Working Capital

The calculation of Working Capital provides additional information and is not defined under GAAP. We define Working Capital as current assets less current liabilities. This measure should not be considered in isolation or as a substitute for any standardized measure under GAAP. This information is intended to provide investors with information about our liquidity.

Other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure.

Liquidity and Capital Resources

As of March 31, 2022 and December 31, 2021, we had total current liabilities of $491,834 and $11,106, respectively, and current assets of $1,168,653 and $976,947, respectively, to meet our current obligations. As of March 31, 2022, we had working capital of $676,810, a decrease of working capital of $289,031 as compared to December 31, 2021, driven primarily by cash used in operations.

18
Table of Contents

Comparison of

For the nine-month period ended September 30, 2021 with the nine-month period ended September 30, 2020.

The revenue for the ninethree months ended September 30, 2021March 31, 2022, cash used in operations was ($145,686) which primarily included the net loss of $146,689 consisted of $78,219 of QVH leasing revenue, and $68,470 of service revenues consisting of excess collections for previously performed procedures totaling $18,470 and a revision to our estimated variable consideration totaling $50,000.  For the same period in 2020, revenue was $156,383, consisting of $69,368 of QVH leasing and $87,015 related to excess collections for previously performed procedures.

During the nine months ended September 30, 2021, we incurred $230,453 of operating, general and administrative expenses compared to $385,642 for the same period in 2020. The decrease is attributable to decreases in payroll expenses of $48,320, consulting expense of $25,153, bad debt expense net of recoveries of $69,912, rent expenses of $7,000 coupled with($229,162) partially offset by an increase of legal feesaccounts payable and accrued liabilities of $8,790, an increase$85,747.

We have a history of $10,268 in computer expensesoperating losses. We have not yet achieved profitable operations and other miscellaneous expense decreasesexpect to incur further losses. We have funded our operations primarily from equity financing. As of approximately $4,000.

As a resultMarch 31, 2022, cash generated from financing activities was not sufficient to fund the full development of the foregoing, we had a net losscomponents of $119,284 for the nine months ended September 30, 2021, comparedEvirontek Integrated Platform, in particular, to a net loss of $247,239 for the nine months ended September 30, 2020.

Liquidity and Capital Resources

For the nine months ended September 30, 2021, cash provided in operations was $35,943 versus cash provided of $406,431 for the nine months ended September 30, 2020. The decrease in cash provided in operations is primarily attributable to timing of collections of accounts receivable for procedures performed prior to 2018. Collections of accounts receivable for the nine months ended September 30, 2021 and 2020 totaled $180,305 and $650,514, respectively.  

Cash used in financing activities for the nine months ended September 30, 2021 consisted of repayments onfund our shareholder loangrowth strategy in the amountshort-term or long-term. The primary need for liquidity is to fund working capital requirements of $60,000. Cash used inthe business, including operational expenses, develop and commercialize the Evirontek Integrated Platform and the capital expenditures associated with that project. The primary source of liquidity has primarily been private financing activities fortransactions. The ability to fund operations, to make planned capital expenditures, to execute on the nine months ended September 30, 2020 were paymentsdevelopment and commercialization of the Evirontek Integrated Platform depends on our note payable to a shareholder of $65,000, payments on our term loan of $460,000 and proceeds of $64,097 related to our Paycheck Protection Program (PPP) loan.

Going Concern Considerations

Since our inception in 1998, until commencement of our spine injury diagnostic operations in August 2009, our expenses substantially exceeded our revenue, resulting in continuing losses and an accumulated deficit from operations of $15,004,698 as of December 31, 2009. Since that time, our accumulated deficit has increased $5,252,769 to $20,257,467 as of September 30, 2021. During the nine months ended September 30, 2021, we realized net revenue of $96,689 and incurred a net loss of $119,284. Successful business operations and our ability to generate cash flowsraise funds from operations, sufficientdebt and/or equity financing which is subject to meetprevailing economic conditions and financial, business and other factors, some of which are beyond our debt obligations are dependent upon obtaining additional financing and achieving a level of collections adequate to support our cost structure. Considering the nature of our business, we are not generating immediate liquidity and sufficient working capital within a reasonable period of time to fund our planned operations and strategic business plan for a period of one year from the filing of this report.control. There can be no assurancesassurance that thereadditional financing will be adequate financing available to us.us when needed or, if available, that it can be obtained on commercially reasonable terms.

15

During the fourth quarterdate of 2018, the decision was madethis Quarterly Report on Form 10-Q/A (Amendment No. 1), we do not have any off-balance-sheet arrangements that have, or are reasonably likely to discontinue involvement in future medical procedures due to our cash position, which also hampers our ability to pay back existing debt to our shareholder (see Note 5—Term Loan). We were not involved in any procedures in 2021 or 2020 and will not resume procedures unless we can access additional capital. The service revenue we have earned has resulted in longer settlement times, which has created a slowdown in cash collections. Additionally, despite our efforts to establish a market for the Quad Video Halo, such market has not met our expectations and we have cut back its development and operations. If we are unable to access additional capital in the near future, these recent developments could have, a material negative impact on our financial performance and could have a material adversecurrent or future effect on our results of operations or financial condition, including, and financial condition.without limitation, such considerations as liquidity and capital resources.

Transactions with Related Parties

Up until March 31, 2022, the Company maintained its executive offices at 5151 Mitchelldale A2, Houston, Texas 77092. This office space encompasses approximately 200 square feet and was provided to us at the rental rate of $1,000 per month under a month-to-month agreement with Northshore Orthopedics, Assoc. (“NSO”), a company owned by William Donovan, M.D., our former director and Chief Executive Officer. The rent included the use of the telephone system, computer server, and copy machines. We discontinued paying rent in December 2021 due to a lack of funds, and since then NSO has provided the Company this office space rent free.

Also, see discussion above regarding the MSA, the Note, the Note Amendment, the Security Agreement and the Security Agreement Amendment.

Changes in or Adoption of Accounting Practices

There were no material changes in or adoption of new accounting practices during the three months ended March 31, 2022.

Critical Accounting Policies

See Note 2 of the accompanying notes to unaudited condensed consolidated financial statements, have been prepared assuming that we will continue as a going concern. This basis of accounting contemplates the recovery of our assets and the satisfaction of liabilities in the normal course of business. The unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.which note is incorporated herein by reference.

19
Table of Contents

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not Applicable.

We are a smaller reporting company as defined by 17 C.F.R. 229 (10)(f)(i) and are not required to provide information under this item.

ITEM 4.CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our principal executive officer and principal financial officer are responsible for establishing and maintaining our disclosure controls and procedures. Such officers have concluded (based upon their evaluation of these controls and procedures as of the end of the period covered by this report) that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in this report is accumulated and communicated to management, including our principal executive and principal financial officer as appropriate, to allow timely decisions regarding required disclosure.

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2022. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective as of March 31, 2022.

Changes in Internal Control Over Financial Reporting

Our principal executive officer and principal financial officer have also indicated that, upon evaluation, there were no changes in our internal control over financial reporting or other factors during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. In addition, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of these inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

20
Table of Contents

16

PART IIOTHER INFORMATION

ITEM 1A. RISK FACTORS

In addition to the other information set forth in this report, one should carefully consider the discussion of various risks and uncertainties contained in Part I, Item 1A, “Risk Factors” in our 20202021 Annual Report on Form 10-K. We believe the risk factors presented in this filing and those presented on our 2020 Form 10-K are the most relevant to our business and could cause our results to differ materially from any forward-looking statements made by us.

The COVID-19 pandemic has had, and is expected to continue to have, an adverse impact on our business, results of operations and financial condition, and other pandemics, epidemics or disease outbreaks could have a similar impact. The extent to which COVID-19 impacts our business will depend on future developments, which are highly uncertain and cannot be predicted.

The recent outbreak of COVID-19, which has been declared by the World Health Organization to be a pandemic, has spread across the globe and is impacting worldwide economic activity. The outbreak has resulted in authorities implementing numerous measures to try to contain the virus, such as travel bans and restrictions, social distancing guidelines, quarantines, shelter in place orders and business shutdowns. These measures have not only negatively impacted consumer spending and business spending habits, they have also adversely impacted and may further impact our workforce and operations and the operations of our customers, suppliers and business partners. The duration of these measures is unknown and may be extended, and additional measures may be imposed. This will likely continue to adversely affect our business, results of operations and financial condition.

The COVID-19 pandemic has made it difficult for us to collect our accounts receivable, as attorney and medical offices are closed resulting in delayed settlements and medical procedures being canceled, which affects our lease revenue. We are uncertain how this pandemic will affect our ability to collect in the future or its overall effect on our lease revenue.

Further, COVID-19 has caused us to modify our business practices, including restricting employee travel, modifying employee work locations, increasing reliance on remote access to our information systems, implementing social distancing and enhanced sanitary measures in our offices. Weoffices, we may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, customers and business partners. There is no certainty that such measures will be sufficient to mitigate the risks posed by the virus or otherwise be satisfactory to government authorities. Further, our enhanced reliance on remote access to our information systems increases our exposure to cybersecurity attacks or data security incidents.

COVID-19 has had, and is expected to continue to have, an adverse impact on our business, results of operations and financial condition. The extent to which the COVID-19 outbreak impacts our business, results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume. Even after the COVID-19 outbreak has subsided, we may continue to experience materially adverse impacts to our business as a result of its global economic impact, including any economic downturn or recession that has occurred or may occur in the future. The impact of COVID-19 may also exacerbate other risks discussed in Part I, "Item“Item 1A. Risk Factors"Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020,2021, any of which could have a material effect on us. This situation is changing rapidly, and additional impacts may arise that we are not aware of currently.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

Not applicable.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

Not applicable.

21
17
Table of Contents

ITEM 6. EXHIBITS

Exhibit No.

Description

3.1

3.1*

Articles of Incorporation dated March 4, 1998. (Incorporated by reference from Form 10-SB filed with the SEC on January 5, 2000.) *

3.2

3.2*

Amended Articles of Incorporation dated April 23, 1998. (Incorporated by reference from Form 10-SB filed with the SEC on January 5, 2000.) *

3.3

3.3*

Amended Articles of Incorporation dated January 4, 2002. (Incorporated by reference from Form 10KSB filed with the SEC on May 21, 2003.) *

3.4

3.4*

Amended Articles of Incorporation dated December 19, 2003. (Incorporated by reference from Form 10-KSB filed with the SEC on May 20, 2004.) *

3.5

3.5*

Amended Articles of Incorporation dated November 4, 2004. (Incorporated by reference from Form 10-KSB filed with the SEC on April 15, 2005) *

3.6

3.6*

Amended Articles of Incorporation dated September 7, 2005. (Incorporated by reference from Form 10-QSB filed with the SEC on November 16, 2005) *

3.7

3.7*

Certificate of Amendment to Certificate of Incorporation (Incorporated by reference from Form 8-K filed with the SEC on October 7, 2015.) *

3.8

3.8*

Certificate of Amendment to Certificate of Incorporation dated January 20, 2021 (Incorporated by reference from Form 10-K filed with the SEC on March 26, 2021.)

3.9*By-Laws dated April 23, 1998. (Incorporated by reference from Form 10-SB filed with the SEC on January 5, 2000.) *

10.1

3.10*

 Certificate of Designations of Preferences and Rights of Series A Convertible Preferred Stock dated March 31, 2022 (Incorporated by reference to Exhibit 3.9 from Form 8-K filed with the SEC on April 4, 2022).

3.11*Certificate of Amendment to Certificate of Incorporation, as amended, dated April 28, 2022 (Incorporated by reference to Exhibit 3.1 from Form 8-K filed with the SEC on May 2, 2022).
10.1*Secured Promissory Note with Peter Dalrymple, dated August 31, 2020 (Incorporated by reference from Form 8-K filed with the SEC on September 2, 2020) *.

10.2

10.2*

Security Agreement with Peter Dalrymple, dated August 31, 2020 (Incorporated by reference from Form 8-K filed with the SEC on September 2, 2020) *.

10.3

10.3*

Letter agreement with Peter Dalrymple, dated October 28, 2021 (Incorporated by reference to Exhibit 10.1 from Form 8-K filed with the SEC on November 2, 2021) *.

10.4

10.4*

Amendment to Secured Promissory Note with Peter Dalrymple, dated October 29, 2021 (Incorporated by reference from Form 8-K filed with the SEC on November 2, 2021) *.

31.1

10.5*
Share Exchange Agreement among Spine Injury Solutions, Inc., Bitech Mining Corporation, its shareholders and Benjamin Tran as Stockholders’ Representative dated as of March 31, 2022 (Incorporated by reference to Exhibit 10.5 from Form 8-K filed with the SEC on April 4, 2022).
10.6*+Management Services Agreement between Spine Injury Solutions, Inc., Quad Video Halo, Inc. and Peter L. Dalrymple dated as of March 31, 2022 (Incorporated by reference to Exhibit 10.6 from Form 8-K filed with the SEC on April 4, 2022).
10.7*Amendment to Secured Promissory Note Agreement between Spine Injury Solutions, Inc., Quad Video Halo, Inc. and Peter L. Dalrymple dated as of March 31, 2022 (Incorporated by reference to Exhibit 10.7 from Form 8-K filed with the SEC on April 4, 2022).

22
Table of Contents

10.8*Amendment to Security Agreement between Spine Injury Solutions, Inc., Quad Video Halo, Inc. and Peter L. Dalrymple dated as of March 31, 2022 (Incorporated by reference to Exhibit 10.8 from Form 8-K filed with the SEC on April 4, 2022).
10.9*†Form of Independent Contractor Agreement (Incorporated by reference to Exhibit 10.1 from Form 8-K filed with the SEC on April 20, 2022).
10.10*†Form of Proprietary Information and Inventions Agreement (Incorporated by reference to Exhibit 10.2 from Form 8-K filed with the SEC on April 20, 2022).
10.11†Form of Restricted Stock Agreement (Incorporated by reference to Exhibit 10.3 from Form 8-K filed with the SEC on April 20, 2022).
31.1Certification of principal executive officer required by Rule 13a – 14(1) or Rule 15d – 14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

Certification of principal financial officer required by Rule 13a – 14(1) or Rule 15d – 14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63.

32.2

Certification of principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63.

101.INS

Inline XBRL Instance Document

101.SCH

Inline XBRL Taxonomy Extension Schema

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase

101.DEF

Inline XBRL Taxonomy Extension Definitions Linkbase

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase

104

Cover Page Interactive Data File (formatted as(embedded within the Inline XBRL and contained in Exhibit 101)

document)

* Incorporated by reference from our previous filings with the SECSEC.

+Certain confidential information has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
Includes management contracts and compensation plans and arrangements.

23
Table of Contents

18

SIGNATURES

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Bitech Technologies Corporation
 

Spine Injury Solutions, Inc.

Date: September 26, 2022By:/s/ Benjamin Tran
 

 Date: November 12, 2021

By: /s/ William F. Donovan, M.D.

Benjamin Tran

William F. Donovan, M.D.

 

Chief Executive Officer (Principal Executive Officer)

Date: September 26, 2022By:/s/ Robert J. Brilon
 Robert J. Brilon
 

 Date: November 12, 2021

By: /s/ John Bergeron

John Bergeron

Chief Financial Officer (Principal Financial and Accounting Officer)

24

19
iso4217:USD xbrli:shares